NASDAQ
Celyad Oncology S.A. (CLYYF) has a current ratio of 1.92x as of Monday, May 25, 2026. This represents a 22.94% decrease compared to its 12-month average of 2.50x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.